Gundram Jung

2PUBLICATIONS
7CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 13, 2022
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro.

Joseph Kauer, Melanie Märklin, Martin Pflügler

|Dec 29, 2020
An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer.

Latifa Zekri, Fabian Vogt, Lukas Osburg

Pageof 1